DXCM - Dexcom Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Surgical & Medical Instruments & Apparatus - DXCM (1093557)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-04-23
DXCMDoubleday RichardEVP Chief Commercial OfficerS - Sale$116.98-2,01682,650-2%-$235,838
2019-04-23
DXCMPacelli Steven RobertEVP Strategy, Corporate DevS - Sale$116.61-3,59696,371-4%-$419,329
2019-04-15
DXCMFoletta Mark GDirS - Sale$118.98-1,00018,147-5%-$118,977
2019-04-15
DXCMSayer Kevin RPres, CEO, COBS - Sale$118.91-6,000306,100-2%-$713,471
2019-04-10
DXCMMurphy Patrick MichaelSVP Legal AffairsS - Sale$115.05-40036,260-1%-$46,020
2019-04-01
DXCMAltman Steven RDirS - Sale$119.60-2,50053,804-4%-$298,999
2019-03-25
DXCMDoubleday RichardEVP Chief Commercial OfficerS - Sale$127.38-2,01684,666-2%-$256,789
2019-03-22
DXCMPacelli Steven RobertEVP Strategy, Corporate DevS - Sale$140.04-3,59699,967-3%-$503,571
2019-03-15
DXCMFoletta Mark GDirS - Sale$150.28-1,00019,147-5%-$150,279
M
2019-03-11
DXCMSayer Kevin RPres, CEO, COBS - Sale$142.83-32,566312,100-9%-$4,651,307
2019-03-12
DXCMPacelli Steven RobertEVP Strategy, Corporate DevS - Sale$142.79-10,811103,563-9%-$1,543,726
2019-03-12
DXCMMurphy Patrick MichaelSVP Legal AffairsS - Sale$142.79-3,96236,660-10%-$565,743
2019-03-12
DXCMMoy JeffreySVP OperationsS - Sale$142.79-8,53166,790-11%-$1,218,160
2019-03-12
DXCMLeach Jacob StevenEVP CTOS - Sale$142.79-8,555127,907-6%-$1,221,587
2019-03-12
DXCMDoubleday RichardEVP Chief Commercial OfficerS - Sale$142.79-10,81186,682-11%-$1,543,726
2019-03-12
DXCMBlackford Quentin S.EVP CFOS - Sale$142.79-5,358100,614-5%-$765,081
2019-03-12
DXCMBalo Andrew K*S - Sale$142.79-10,91777,217-12%-$1,558,862
M
2019-03-11
DXCMAce Heather SSVP HRS - Sale$142.90-10,46166,334-14%-$1,494,833
2019-03-12
DXCMAbbey DonaldEVP Quality, Regulatory AffS - Sale$142.79-7,65395,423-7%-$1,092,789
2019-03-08
DXCMMurphy Patrick MichaelSVP Legal AffairsS - Sale$141.56-40040,622-1%-$56,624
2019-02-15
DXCMFoletta Mark GDirS - Sale$148.72-1,00020,147-5%-$148,723
2019-02-11
DXCMSayer Kevin RPres, CEO, COBS - Sale$148.90-6,000308,837-2%-$893,400
2019-02-08
DXCMMurphy Patrick MichaelSVP Legal AffairsS - Sale$142.76-40029,308-1%-$57,104
2019-02-08
DXCMMurphy Patrick MichaelSVP Legal AffairsS - Sale$142.76-40029,308-1%-$57,104
2019-01-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$149.74-3,114101,404-3%-$466,303
2019-01-14
DXCMKahn BarbaraDirS - Sale$142.30-10,63120,266-34%-$1,512,827
2019-01-14
DXCMSayer Kevin RPres, CEO, COBS - Sale$140.99-6,000314,837-2%-$845,930
2019-01-10
DXCMMurphy Patrick MichaelSVP, GC, Chief Compliance OffS - Sale$138.75-40029,708-1%-$55,500
2019-01-02
DXCMAltman Steven RDirS - Sale$117.04-2,50056,304-4%-$292,593
2018-12-21
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$109.34-1,51080,916-2%-$165,101
2018-12-21
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$109.41-3,114104,518-3%-$340,700
2018-12-14
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$121.23-5,00073,105-6%-$606,167
2018-12-10
DXCMMurphy Patrick MichaelSVP, GC, Chief Compliance OffS - Sale$121.90-40030,108-1%-$48,760
D
2018-12-10
DXCMSayer Kevin RPres, CEO, COBS - Sale+OE$121.67-11,162320,837-3%-$1,358,041
2018-11-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$121.35-1,73682,426-2%-$210,664
2018-11-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$121.42-3,114107,632-3%-$378,105
2018-11-14
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$143.13-5,00078,105-6%-$715,664
D
2018-11-12
DXCMSayer Kevin RPres, CEO, COBS - Sale+OE$146.43-11,161320,837-3%-$1,634,284
2018-11-09
DXCMMurphy Patrick MichaelSVP, GC, Chief Compliance OffS - Sale$148.11-40030,508-1%-$59,244
2018-11-09
DXCMAce Heather SSVP HRS - Sale$147.32-4,25865,081-6%-$627,294
2018-11-09
DXCMAbbey DonaldEVP, Quality, Regulatory AfrsS - Sale$149.30-10,55088,089-11%-$1,575,159
2018-10-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$128.72-1,73684,162-2%-$223,466
2018-10-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$128.85-3,114110,746-3%-$401,253
2018-10-12
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$124.79-5,00083,105-6%-$623,934
2018-10-10
DXCMMurphy Patrick MichaelSVP, GC, Chief Compliance OffS - Sale$122.20-40030,908-1%-$48,880
D
2018-10-08
DXCMSayer Kevin RPres, CEO, COBS - Sale+OE$124.76-11,161320,837-3%-$1,392,433
2018-10-01
DXCMAltman Steven RDirS - Sale$135.65-2,50058,804-4%-$339,134
2018-09-28
DXCMLeach Jacob StevenCTOS - Sale$143.95-47,600121,108-28%-$6,852,139
2018-09-24
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$141.20-1,73685,898-2%-$245,129
2018-09-24
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$141.25-3,114113,860-3%-$439,841
2018-09-14
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$145.17-5,00088,105-5%-$725,851
2018-09-11
DXCMBlackford Quentin S.EVP, CFO, PFO, PAOS - Sale$147.04-8,44087,131-9%-$1,241,028
2018-09-10
DXCMMoy JeffreySVP, OperationsS - Sale$143.53-10,33063,245-14%-$1,482,667
2018-09-10
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$143.75-5,48387,634-6%-$788,210
2018-09-10
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$143.75-5,58793,105-6%-$803,160
2018-09-10
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$143.75-5,483116,974-4%-$788,210
2018-09-10
DXCMMurphy Patrick MichaelVP, Legal Aff, Chf Compl OfcrS - Sale$143.69-2,37231,308-7%-$340,825
2018-09-10
DXCMLeach Jacob StevenSVP, Research, DevelopmentS - Sale$143.75-4,614153,708-3%-$663,286
2018-09-10
DXCMAce Heather SSVP HRS - Sale$143.75-1,83269,339-3%-$263,360
2018-09-10
DXCMAbbey DonaldEVP, Quality, Regulatory AfrsS - Sale$143.75-2,30398,639-2%-$331,068
2018-09-10
DXCMBlackford Quentin S.EVP, CFO, PFO, PAOS - Sale$143.75-7,14995,571-7%-$1,027,706
D
2018-09-10
DXCMSayer Kevin RPres, CEO, COBS - Sale+OE$143.62-25,495320,837-7%-$3,661,573
2018-08-24
DXCMAltman Steven RDirS - Sale$136.47-5,00061,304-8%-$682,359
2018-08-24
DXCMFoletta Mark GDirS - Sale$137.50-1,00021,147-5%-$137,503
D
2018-08-24
DXCMLeach Jacob StevenSVP, Research, DevelopmentS - Sale+OE$138.32-20,577158,302-12%-$2,846,155
2018-08-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$140.03-2,58492,912-3%-$361,833
2018-08-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$139.96-3,114122,457-2%-$435,843
2018-08-14
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$124.25-5,00098,567-5%-$621,253
D
2018-08-13
DXCMSayer Kevin RPres, CEO, COBS - Sale+OE$123.22-11,161335,171-3%-$1,375,211
2018-08-10
DXCMMurphy Patrick MichaelVP, Legal Aff, Chf Compl OfcrS - Sale$124.19-12,50033,680-27%-$1,552,310
2018-08-06
DXCMAugustinos NicholasDirS - Sale$121.33-12,30022,164-36%-$1,492,381
2018-08-01
DXCMMoy JeffreySVP, OperationsS - Sale$94.13-5,83173,572-7%-$548,872
2018-07-25
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$101.91-3,114125,571-2%-$317,335
2018-07-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$102.48-2,58195,496-3%-$264,513
2018-07-16
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$99.56-5,000103,567-5%-$497,816
2018-07-16
DXCMGregg Terrance HExec COBS - Sale$99.56-10,000504,017-2%-$995,561
2018-07-09
DXCMSayer Kevin RPres, CEOS - Sale$99.79-14,219335,171-4%-$1,418,856
2018-06-28
DXCMMoy JeffreySVP, OperationsS - Sale$92.48-59,19379,403-43%-$5,474,297
2018-06-25
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$98.58-2,58198,077-3%-$254,431
2018-06-15
DXCMGregg Terrance HExec COBS - Sale$97.81-10,000514,017-2%-$978,096
2018-06-12
DXCMTopol EricDirS - Sale$100.10-20,00088,257-18%-$2,001,998
2018-05-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$86.00-2,581100,658-3%-$221,963
2018-05-15
DXCMGregg Terrance HExec COBS - Sale$85.90-10,000524,017-2%-$858,974
D
2018-05-14
DXCMSkyler Jay SDirS - Sale+OE$88.00-30,00036,810-45%-$2,640,000
DM
2018-05-08
DXCMLeach Jacob StevenSVP, Research, DevelopmentS - Sale+OE$84.87-13,168158,478-8%-$1,117,567
D
2018-05-09
DXCMSayer Kevin RPres, CEOS - Sale+OE$84.37-17,245349,390-5%-$1,454,992
D
2018-05-08
DXCMSkyler Jay SDirS - Sale+OE$85.11-31,46436,810-46%-$2,678,024
2018-04-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$73.09-2,581103,239-2%-$188,649
2018-04-16
DXCMGregg Terrance HExec COBS - Sale$73.04-10,000534,017-2%-$730,414
2018-03-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$68.44-2,581105,820-2%-$176,643
2018-03-15
DXCMGregg Terrance HExec COBS - Sale$65.51-10,000544,017-2%-$655,122
2018-02-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$56.32-1,63879,021-2%-$92,252
2018-02-15
DXCMGregg Terrance HExec COBS - Sale$55.91-10,000516,902-2%-$559,095
2018-01-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$54.67-1,63580,659-2%-$89,384
2018-01-16
DXCMGregg Terrance HExec COBS - Sale$56.86-10,000526,902-2%-$568,588
2017-12-26
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$56.39-1,63582,294-2%-$92,204
2017-12-12
DXCMSayer Kevin RPres, CEOS - Sale$58.85-6,000280,826-2%-$353,092
2017-12-11
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$61.23-3,24579,547-4%-$198,691
2017-11-29
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$60.12-2,90096,426-3%-$174,340
2017-11-29
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$60.00-6,49082,792-7%-$389,400
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top